Total Funding
49
30
Total FundingSeed raised
Growth Score 49 in past quarter
-2 pts
Heat Score 30 in past quarter
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
248734
GestVision, Inc. is commercializing a point of care diagnostic test for preeclampsia
Wendy Davis: Founder & CEO- Leslie Rose: Sr. Director, Clinical OperationsPast Role: TransMedics, Senior Director of Clinical Affairs
About the Company
GestVision, Inc. is commercializing a point of care diagnostic test for preeclampsia. The pregnancy-related condition is often characterized by the symptoms of high blood pressure and protein in the urine. Left untreated, the condition can lead to seizures and even death. Preeclampsia is an equal opportunity problem and is of concern in both
developed and developing nations. The US is not immune and sees preeclampsia as a growing problem.
Women Founded
Women Led

